ERIS Lifesciences Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '23
Sep '23
Jun '23
Mar '23
Dec '22
Total Qtr Revenue cr
490.49
508.78
467.61
403.80
425.50
Other Income Qtr Cr4.203.480.991.002.24
Operating Revenues Qtr486.30505.30466.62402.80423.26

*All values are in Cr.

Operating Expenses Qtr
310.79
324.16
296.88
283.90
286.06
Operating Profit Qtr
175.51
181.14
169.75
118.89
137.20
EBIDT Qtr Cr
179.71
184.63
170.73
119.90
139.44
Depreciation Qtr
45.72
42.09
40.89
35.13
29.90
Net Profit Qtr
102.74
123.43
94.86
65.42
101.86
Basic EPS Qtr
7.55
9.08
6.97
4.81
7.49
Open Demat Account
or Resume your Application
+91 -

personImage